Lipid and lipoprotein abnormalities in acute lymphoblastic leukemia survivors

J Lipid Res. 2017 May;58(5):982-993. doi: 10.1194/jlr.M072207. Epub 2017 Mar 8.

Abstract

Survivors of acute lymphoblastic leukemia (ALL), the most common cancer in children, are at increased risk of developing late cardiometabolic conditions. However, the mechanisms are not fully understood. This study aimed to characterize the plasma lipid profile, Apo distribution, and lipoprotein composition of 80 childhood ALL survivors compared with 22 healthy controls. Our results show that, despite their young age, 50% of the ALL survivors displayed dyslipidemia, characterized by increased plasma triglyceride (TG) and LDL-cholesterol, as well as decreased HDL-cholesterol. ALL survivors exhibited lower plasma Apo A-I and higher Apo B-100 and C-II levels, along with elevated Apo C-II/C-III and B-100/A-I ratios. VLDL fractions of dyslipidemic ALL survivors contained more TG, free cholesterol, and phospholipid moieties, but less protein. Differences in Apo content were found between ALL survivors and controls for all lipoprotein fractions except HDL3 HDL2, especially, showed reduced Apo A-I and raised Apo A-II, leading to a depressed Apo A-I/A-II ratio. Analysis of VLDL-Apo Cs disclosed a trend for higher Apo C-III1 content in dyslipidemic ALL survivors. In conclusion, this thorough investigation demonstrates a high prevalence of dyslipidemia in ALL survivors, while highlighting significant abnormalities in their plasma lipid profile and lipoprotein composition. Special attention must, therefore, be paid to these subjects given the atherosclerotic potency of lipid and lipoprotein disorders.

Keywords: apolipoproteins; atherosclerosis; cancer; cardiovascular diseases; clinical studies; dyslipidemia; lipid and lipoprotein metabolism; metabolic syndrome.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apolipoproteins E / blood
  • Apolipoproteins E / genetics
  • Cancer Survivors*
  • Dyslipidemias / complications
  • Female
  • Humans
  • Lipoprotein Lipase / genetics
  • Lipoproteins / blood
  • Lipoproteins / genetics
  • Lipoproteins / metabolism*
  • Male
  • Polymorphism, Genetic
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / blood
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / complications
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / genetics
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / metabolism*
  • Receptors, LDL / genetics
  • Young Adult

Substances

  • Apolipoproteins E
  • Lipoproteins
  • Receptors, LDL
  • LPL protein, human
  • Lipoprotein Lipase